Faith Stevison

580 total citations
13 papers, 301 citations indexed

About

Faith Stevison is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Faith Stevison has authored 13 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Faith Stevison's work include Retinoids in leukemia and cellular processes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Faith Stevison is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Faith Stevison collaborates with scholars based in United States, South Korea and Japan. Faith Stevison's co-authors include Nina Isoherranen, Sasmita Tripathy, Jing Jing, Cathryn A. Hogarth, Samuel L.M. Arnold, John K. Amory, Travis Kent, Kevin Ostrowski, John Gannon and Thomas J. Walsh and has published in prestigious journals such as Blood, Analytical Chemistry and Cancer Research.

In The Last Decade

Faith Stevison

13 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faith Stevison United States 10 173 81 78 49 39 13 301
Xiaowen Hu China 10 380 2.2× 77 1.0× 175 2.2× 35 0.7× 42 1.1× 20 555
Raie Bekele United States 7 218 1.3× 33 0.4× 69 0.9× 36 0.7× 22 0.6× 11 307
Laura M. Popoviciu United States 6 139 0.8× 38 0.5× 92 1.2× 26 0.5× 43 1.1× 6 333
Susanne Schüler‐Toprak Germany 13 136 0.8× 23 0.3× 119 1.5× 140 2.9× 41 1.1× 23 378
Tamer Zeren United States 9 127 0.7× 31 0.4× 108 1.4× 27 0.6× 70 1.8× 16 343
Andréa Fournier Canada 12 240 1.4× 103 1.3× 56 0.7× 115 2.3× 22 0.6× 14 416
Tania Z. Thomas United States 5 273 1.6× 159 2.0× 85 1.1× 119 2.4× 17 0.4× 5 415
J.R. Williams United States 9 270 1.6× 93 1.1× 108 1.4× 38 0.8× 25 0.6× 16 484
Zannel Blanchard United States 8 183 1.1× 33 0.4× 110 1.4× 83 1.7× 46 1.2× 11 383
Patricia A. Toniolo United States 7 365 2.1× 36 0.4× 108 1.4× 67 1.4× 84 2.2× 8 515

Countries citing papers authored by Faith Stevison

Since Specialization
Citations

This map shows the geographic impact of Faith Stevison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faith Stevison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faith Stevison more than expected).

Fields of papers citing papers by Faith Stevison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faith Stevison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faith Stevison. The network helps show where Faith Stevison may publish in the future.

Co-authorship network of co-authors of Faith Stevison

This figure shows the co-authorship network connecting the top 25 collaborators of Faith Stevison. A scholar is included among the top collaborators of Faith Stevison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faith Stevison. Faith Stevison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lim, Sun Min, Stefanie S. Schalm, Sewon Park, et al.. (2024). BLU-945, a potent and selective next-generation EGFR TKI, has antitumor activity in models of osimertinib-resistant non-small-cell lung cancer. Therapeutic Advances in Medical Oncology. 16. 7 indexed citations
2.
3.
4.
Schalm, Stefanie S., Sangbin Lim, Rich Woessner, et al.. (2020). 1296P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC. Annals of Oncology. 31. S839–S839. 43 indexed citations
5.
Schalm, Stefanie S., Sangbin Lim, Rich Woessner, et al.. (2020). 384P BLU-945, a highly potent and selective 4th generation EGFR TKI for the treatment of EGFR T790M/C797S resistant NSCLC. Annals of Oncology. 31. S1391–S1391. 12 indexed citations
6.
Duarte, Julio D., et al.. (2019). Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue. Clinical and Translational Science. 12(4). 416–423. 5 indexed citations
7.
Stevison, Faith, Jane R. Kenny, Susan Wong, et al.. (2019). Does In Vitro Cytochrome P450 Downregulation Translate to In Vivo Drug‐Drug Interactions? Preclinical and Clinical Studies With 13‐cis‐Retinoic Acid. Clinical and Translational Science. 12(4). 350–360. 22 indexed citations
8.
Stevison, Faith, Guo Zhong, Traci Topping, et al.. (2018). Sources ofall-transretinal oxidation independent of the aldehyde dehydrogenase 1A isozymes exist in the postnatal testis†. Biology of Reproduction. 100(2). 547–560. 20 indexed citations
9.
Amory, John K., Kevin Ostrowski, John Gannon, et al.. (2017). Isotretinoin administration improves sperm production in men with infertility from oligoasthenozoospermia: a pilot study. Andrology. 5(6). 1115–1123. 39 indexed citations
10.
Stevison, Faith, Cathryn A. Hogarth, Sasmita Tripathy, Travis Kent, & Nina Isoherranen. (2017). Inhibition of the all-trans Retinoic Acid (atRA) Hydroxylases CYP26A1 and CYP26B1 Results in Dynamic, Tissue-Specific Changes in Endogenous atRA Signaling. Drug Metabolism and Disposition. 45(7). 846–854. 34 indexed citations
11.
Stevison, Faith, Jing Jing, Sasmita Tripathy, & Nina Isoherranen. (2015). Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer. Advances in pharmacology. 74. 373–412. 64 indexed citations
12.
Arnold, Samuel L.M., Faith Stevison, & Nina Isoherranen. (2015). Impact of Sample Matrix on Accuracy of Peptide Quantification: Assessment of Calibrator and Internal Standard Selection and Method Validation. Analytical Chemistry. 88(1). 746–753. 23 indexed citations
13.
Borate, Uma, Amir T. Fathi, Bijal Shah, et al.. (2013). A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma. Blood. 122(21). 1437–1437. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaowen Hu Breakdown of academic impact, for papers by Raie Bekele Breakdown of academic impact, for papers by Laura M. Popoviciu Breakdown of academic impact, for papers by Susanne Schüler‐Toprak Breakdown of academic impact, for papers by Tamer Zeren Breakdown of academic impact, for papers by Andréa Fournier Breakdown of academic impact, for papers by Tania Z. Thomas Breakdown of academic impact, for papers by J.R. Williams Breakdown of academic impact, for papers by Zannel Blanchard Breakdown of academic impact, for papers by Patricia A. Toniolo
Rankless by CCL
2026